Chronic Lymphocytic Leukemia (CLL) is characterized by a progressive accumulation of monoclonal CD5+/CD19+/IgMlow/IgDlow mature B-cells in the blood, bone marrow, lymph nodes and spleen, with an increased resistance to apoptosis and a low proliferation rate [1]. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.